Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis PD Peng, MG Van Vledder, S Tsai, MC De Jong, M Makary, J Ng, BH Edil, ... Hpb 13 (7), 439-446, 2011 | 430 | 2011 |
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models S Tsai, L McOlash, K Palen, B Johnson, C Duris, Q Yang, MB Dwinell, ... BMC cancer 18, 1-13, 2018 | 346 | 2018 |
Circulating giant macrophages as a potential biomarker of solid tumors DL Adams, SS Martin, RK Alpaugh, M Charpentier, S Tsai, RC Bergan, ... Proceedings of the National Academy of Sciences 111 (9), 3514-3519, 2014 | 297 | 2014 |
Plasma extracellular RNA profiles in healthy and cancer patients T Yuan, X Huang, M Woodcock, M Du, R Dittmar, Y Wang, S Tsai, M Kohli, ... Scientific reports 6 (1), 19413, 2016 | 285 | 2016 |
Microwave ablation for hepatic malignancies: a multiinstitutional analysis RT Groeschl, CHC Pilgrim, EM Hanna, KA Simo, RZ Swan, D Sindram, ... Annals of surgery 259 (6), 1195-1200, 2014 | 268 | 2014 |
Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm? KK Christians, S Tsai, A Mahmoud, P Ritch, JP Thomas, L Wiebe, T Kelly, ... The oncologist 19 (3), 266-274, 2014 | 213 | 2014 |
Importance of normalization of CA19-9 levels following neoadjuvant therapy in patients with localized pancreatic cancer S Tsai, B George, D Wittmann, PS Ritch, AN Krepline, M Aldakkak, ... Annals of surgery 271 (4), 740-747, 2020 | 169 | 2020 |
Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy KK Christians, JW Heimler, B George, PS Ritch, BA Erickson, F Johnston, ... Surgery 159 (3), 893-900, 2016 | 130 | 2016 |
Two-stage strategy for patients with extensive bilateral colorectal liver metastases S Tsai, HP Marques, MC De Jong, P Mira, V Ribeiro, MA Choti, ... Hpb 12 (4), 262-269, 2010 | 129 | 2010 |
A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer H Nasief, C Zheng, D Schott, W Hall, S Tsai, B Erickson, X Allen Li NPJ precision oncology 3 (1), 25, 2019 | 128 | 2019 |
Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis JP Silva, NG Berger, S Tsai, KK Christians, CN Clarke, H Mogal, S White, ... HPB 19 (8), 659-666, 2017 | 110 | 2017 |
Pharmacological ascorbate radiosensitizes pancreatic cancer J Du, JA Cieslak III, JL Welsh, ZA Sibenaller, BG Allen, BA Wagner, ... Cancer research 75 (16), 3314-3326, 2015 | 110 | 2015 |
Importance of lean body mass in the oncologic patient S Tsai Nutrition in Clinical Practice 27 (5), 593-598, 2012 | 109 | 2012 |
Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study S Tsai, MA Choti, L Assumpcao, JL Cameron, AL Gleisner, JM Herman, ... Journal of Gastrointestinal Surgery 14 (7), 1143-1150, 2010 | 109 | 2010 |
Surgical management of hepatic hemangiomas: a multi‐institutional experience JT Miura, A Amini, R Schmocker, S Nichols, D Sukato, ER Winslow, ... HPB 16 (10), 924-928, 2014 | 108 | 2014 |
Arterial resection at the time of pancreatectomy for cancer KK Christians, CHC Pilgrim, S Tsai, P Ritch, B George, B Erickson, P Tolat, ... Surgery 155 (5), 919-926, 2014 | 108 | 2014 |
Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation G Cheng, J Zielonka, D McAllister, S Tsai, MB Dwinell, B Kalyanaraman British journal of cancer 111 (1), 85-93, 2014 | 102 | 2014 |
Non-metastatic pancreatic cancer: resectable, borderline resectable, and locally advanced-definitions of increasing importance for the optimal delivery of multimodality therapy DB Evans, B George, S Tsai Annals of Surgical Oncology 22, 3409-3413, 2015 | 98 | 2015 |
Chemotherapy for surgically resected intrahepatic cholangiocarcinoma JT Miura, FM Johnston, S Tsai, B George, J Thomas, D Eastwood, ... Annals of surgical oncology 22, 3716-3723, 2015 | 94 | 2015 |
CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis I Roy, NP Zimmerman, AC Mackinnon, S Tsai, DB Evans, MB Dwinell PloS one 9 (3), e90400, 2014 | 94 | 2014 |